P2X7 gene polymorphisms and risk assessment for pulmonary tuberculosis in Asian Indians

Venkatasubramanian Sambasivan1, Kolluri Janaki Rama Murthy, Ravindra Reddy

  • 1Department of Genetics, Bhagwan Mahavir Medical Research Centre, Hyderabad, India.

Disease Markers
|February 19, 2010
PubMed
Abstract

Insights

Certain P2X7 receptor gene variations, specifically the -762C allele and 1729T allele, are linked to an increased risk of developing pulmonary tuberculosis (PTB). These findings may aid in identifying individuals susceptible to PTB.

Area of Science:

  • Immunogenetics
  • Molecular Biology
  • Infectious Diseases

Background:

  • Pulmonary tuberculosis (PTB) is a significant global health concern.
  • Macrophages and the purinergic P2X7 receptor are crucial in tuberculosis immunopathogenesis.
  • Extracellular ATP signaling via P2X7 receptors can enhance macrophage bactericidal activity.

Purpose of the Study:

  • To investigate the association between specific P2X7 receptor gene polymorphisms (-762 T/C, 1513A/C, 1729T/A) and the risk of developing PTB.
  • To determine if these polymorphisms are risk factors for PTB in the Asian Indian population.

Main Methods:

  • A case-control study was conducted with 156 PTB patients and 100 healthy controls.
  • Genotyping of P2X7 polymorphisms was performed using Polymerase Chain Reaction (PCR) and Restriction Fragment Length Polymorphism (RFLP) analysis.

Main Results:

  • The -762 C allele of the P2X7 receptor gene showed a significant association with PTB (p=0.0051, OR=1.6972).
  • The 1729 T allele was strongly associated with an increased risk of PTB (p < 0.0005, OR=2.4623).
  • No significant association was found for the 1513A/C polymorphism.

Conclusions:

  • The P2X7 receptor polymorphisms, specifically the -762C and 1729T alleles, are significantly associated with PTB in the studied Asian Indian population.
  • These genetic variations may serve as potential biomarkers for identifying individuals at higher risk of developing tuberculosis.

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...